Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can lead to the induction of apoptosis in tumor or infected cells. However, activation of TRAIL signaling may also trigger non-apoptotic pathways in cancer and in non-transformed cells, i.e. immune cells. Here, we review the current knowledge on non-canonical TRAIL signaling. The biological outcomes of TRAIL signaling in immune and malignant cells is presented and explained, with a focus on the role of TRAIL for natural killer (NK) cell function. Furthermore, we highlight the technical difficulties in dissecting the precise molecular mechanisms involved in the switch between apoptotic and non-apoptotic TRAIL signaling. Finally, we d...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
AbstractThe TNF-related apoptosis-inducing ligand (TRAIL) offers great promise as a cancer therapeut...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo1L is a death ligand, a cytokine ...
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfa...
© 2004 Dr. Erika CretneyTumor necrosis factor (TNF)-related apoptosis-inducing ligand [TRAIL or Apo-...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
AbstractThe TNF-related apoptosis-inducing ligand (TRAIL) offers great promise as a cancer therapeut...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo1L is a death ligand, a cytokine ...
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfa...
© 2004 Dr. Erika CretneyTumor necrosis factor (TNF)-related apoptosis-inducing ligand [TRAIL or Apo-...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
International audienceTumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a mem...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...
AbstractThe TNF-related apoptosis-inducing ligand (TRAIL) offers great promise as a cancer therapeut...
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based therapy is currently evaluated...